Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Down0.08% Nasdaq Down0.11%

Keryx Biopharmaceuticals Inc. (KERX)

-NasdaqCM

8.03 Up 0.15(1.90%) 4:00PM EDT|After Hours : 8.03 0.00 (0.00%) 4:37PM EDT

Add to Portfolio
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):1.6
Mean Recommendation (last week):1.5
Change:0.1

* (Strong Buy) 1.0 - 5.0 (Sell)Compare to Industry

Price Target Summary
Mean Target:12.44
Median Target:13.00
High Target:15.00
Low Target:8.00
No. of Brokers:9

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
Dec 12, 2012Maxim GroupInitiated Buy
Nov 12, 2012Burrill Institutional ResearchInitiated Mkt Outperform
May 9, 2012Ladenburg ThalmannUpgradeNeutralBuy
Apr 2, 2012Ladenburg ThalmannDowngradeBuyNeutral
May 16, 2011OppenheimerInitiated Outperform
May 5, 2011MLV CapitalInitiated Buy
Mar 15, 2011JMP SecuritiesInitiated Mkt Outperform
Feb 28, 2010Rodman & RenshawInitiated Mkt Outperform
Feb 24, 2010Roth CapitalInitiated Buy
Mar 10, 2008Banc of America SecDowngradeBuyNeutral

More Upgrades & Downgrades for KERX

Data provided by Briefing.com - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy4444
Buy5444
Hold0000
Underperform0000
Sell0000

Data provided by Thomson/First Call


Currency in USD.